Hepatic Venous Pressure Gradient.
作者信息
Bochnakova Teodora
机构信息
Dotter Institute of Interventional Radiology Oregon Health & Science University Portland OR.
出版信息
Clin Liver Dis (Hoboken). 2021 Apr 13;17(3):144-148. doi: 10.1002/cld.1031. eCollection 2021 Mar.
Abstract
摘要
相似文献
1
Hepatic Venous Pressure Gradient.
Clin Liver Dis (Hoboken). 2021 Apr 13;17(3):144-148. doi: 10.1002/cld.1031. eCollection 2021 Mar.
2
Hepatic venous pressure gradient supplements liver biopsy in the diagnosis of cirrhosis.
J Clin Gastroenterol. 2008 Feb;42(2):199-203. doi: 10.1097/01.mcg.0000225681.45088.48.
3
Short-term effects of propranolol on portal venous pressure.
Hepatology. 1986 Jan-Feb;6(1):101-6. doi: 10.1002/hep.1840060119.
4
Hepatic venous pressure gradient measurement in patients with liver cirrhosis: a correlation with disease severity and variceal bleeding.
Medicina (Kaunas). 2009;45(1):8-13.
5
Hepatic venous pressure gradient measurements to assess response to primary prophylaxis in patients with cirrhosis: a decision analytical study.
Aliment Pharmacol Ther. 2003 Jan;17(1):145-53. doi: 10.1046/j.1365-2036.2003.01391.x.
6
[Invasive diagnosis of portal hypertension in cirrhosis: a critical evaluation of the hepatic venous pressure gradient measurement].
Gastroenterol Clin Biol. 2005 Oct;29(10):988-96. doi: 10.1016/s0399-8320(05)88171-0.
7
Hepatic venous pressure gradient after portal vein embolization: An accurate predictor of future liver remnant hypertrophy.
Surgery. 2018 Aug;164(2):227-232. doi: 10.1016/j.surg.2018.03.014. Epub 2018 May 10.
8
Role of hepatic hemodynamic study in the evaluation of patients with cirrhosis.
Hepatogastroenterology. 2003 Nov-Dec;50(54):2052-6.
9
10
Shear-wave elastography: a noninvasive tool for monitoring changing hepatic venous pressure gradients in patients with cirrhosis.
Radiology. 2014 Dec;273(3):917-26. doi: 10.1148/radiol.14140008. Epub 2014 Jul 14.
引用本文的文献
1
Elevated hydrostatic pressure dysregulates lipid metabolism of hepatocytes.
J Physiol Biochem. 2025 Aug 11. doi: 10.1007/s13105-025-01121-7.
2
The application of EUS-guided portal pressure gradient measurement with concomitant EUS-liver elastography and EUS-guided liver biopsy in patients with chronic liver disease: a single center experience.
Therap Adv Gastroenterol. 2025 Jul 30;18:17562848251359015. doi: 10.1177/17562848251359015. eCollection 2025.
3
Advances in the diagnosis and management of clinically significant portal hypertension in cirrhosis: A narrative review.
World J Hepatol. 2025 Jun 27;17(6):104761. doi: 10.4254/wjh.v17.i6.104761.
4
The liver's dilemma: sensing real danger in a sea of PAMPs: the (arterial) sinusoidal segment theory.
Front Immunol. 2025 Jan 27;15:1503063. doi: 10.3389/fimmu.2024.1503063. eCollection 2024.
5
Pulmonary hypertension post-liver transplant: A case report.
World J Gastrointest Surg. 2024 Dec 27;16(12):3875-3880. doi: 10.4240/wjgs.v16.i12.3875.
6
Standard technique in Japan for measuring hepatic venous pressure gradient.
J Gastroenterol. 2025 Jan;60(1):24-31. doi: 10.1007/s00535-024-02182-z. Epub 2024 Dec 9.
7
Prognostic Impact of Metabolic Syndrome and Steatotic Liver Disease in Hepatocellular Carcinoma Using Machine Learning Techniques.
Metabolites. 2024 May 27;14(6):305. doi: 10.3390/metabo14060305.
8
Endoscopic ultrasound-guided portal pressure gradient measurement: a systematic review and meta-analysis.
Ann Gastroenterol. 2024 May-Jun;37(3):356-361. doi: 10.20524/aog.2024.0882. Epub 2024 Apr 29.
9
The clinical value of the hepatic venous pressure gradient in patients undergoing hepatic resection for hepatocellular carcinoma with or without liver cirrhosis.
Open Med (Wars). 2024 Mar 8;19(1):20230851. doi: 10.1515/med-2023-0851. eCollection 2024.
10
Development of a Direct Non-Puncture Device for Measuring Portal Venous Pressure during Liver Transplantation-A Swine Model.
Biosensors (Basel). 2023 Nov 30;13(12):1007. doi: 10.3390/bios13121007.
本文引用的文献
1
What's new in portal hypertension?
Liver Int. 2020 Feb;40 Suppl 1:122-127. doi: 10.1111/liv.14366.
2
A step forward to accurately predict mortality in cirrhotic patients undergoing elective surgery: The role of the hepatic venous pressure gradient.
J Hepatol. 2019 Nov;71(5):862-863. doi: 10.1016/j.jhep.2019.09.001. Epub 2019 Sep 23.
3
Advances in therapeutic options for portal hypertension.
Therap Adv Gastroenterol. 2018 Nov 25;11:1756284818811294. doi: 10.1177/1756284818811294. eCollection 2018.
4
Managing portal hypertension in patients with liver cirrhosis.
F1000Res. 2018 May 2;7. doi: 10.12688/f1000research.13943.1. eCollection 2018.
5
Primary constrained TIPS for treating refractory ascites or variceal bleeding secondary to hepatic cirrhosis.
Br J Radiol. 2018 Feb;91(1083):20170409. doi: 10.1259/bjr.20170409. Epub 2017 Dec 15.
6
Use of Statins in Patients with Chronic Liver Disease and Cirrhosis: Current Views and Prospects.
Curr Gastroenterol Rep. 2017 Sep;19(9):43. doi: 10.1007/s11894-017-0584-7.
7
Invasive and non-invasive assessment of portal hypertension.
Hepatol Int. 2018 Feb;12(Suppl 1):44-55. doi: 10.1007/s12072-017-9795-0. Epub 2017 Mar 30.
8
Indications of Liver Biopsy in the Era of Noninvasive Assessment of Liver Fibrosis.
J Clin Exp Hepatol. 2015 Dec;5(4):314-9. doi: 10.1016/j.jceh.2015.08.005. Epub 2015 Oct 23.
9
Risk factors for early rebleeding and mortality in acute variceal hemorrhage.
World J Gastroenterol. 2014 Dec 21;20(47):17941-8. doi: 10.3748/wjg.v20.i47.17941.
10
Hepatic venous pressure gradient: clinical use in chronic liver disease.
Clin Mol Hepatol. 2014 Mar;20(1):6-14. doi: 10.3350/cmh.2014.20.1.6. Epub 2014 Mar 26.
Zotero 插件